» Articles » PMID: 36357506

R1441C and G2019S LRRK2 Knockin Mice Have Distinct Striatal Molecular, Physiological, and Behavioral Alterations

Overview
Journal Commun Biol
Specialty Biology
Date 2022 Nov 10
PMID 36357506
Authors
Affiliations
Soon will be listed here.
Abstract

LRRK2 mutations are closely associated with Parkinson's disease (PD). Convergent evidence suggests that LRRK2 regulates striatal function. Here, by using knock-in mouse lines expressing the two most common LRRK2 pathogenic mutations-G2019S and R1441C-we investigated how LRRK2 mutations altered striatal physiology. While we found that both R1441C and G2019S mice displayed reduced nigrostriatal dopamine release, hypoexcitability in indirect-pathway striatal projection neurons, and alterations associated with an impaired striatal-dependent motor learning were observed only in the R1441C mice. We also showed that increased synaptic PKA activities in the R1441C and not G2019S mice underlie the specific alterations in motor learning deficits in the R1441C mice. In summary, our data argue that LRRK2 mutations' impact on the striatum cannot be simply generalized. Instead, alterations in electrochemical, electrophysiological, molecular, and behavioral levels were distinct between LRRK2 mutations. Our findings offer mechanistic insights for devising and optimizing treatment strategies for PD patients.

Citing Articles

Selective dopaminergic neurotoxicity modulated by inherent cell-type specific neurobiology.

Currim F, Tanwar R, Brown-Leung J, Paranjape N, Liu J, Sanders L Neurotoxicology. 2024; 103:266-287.

PMID: 38964509 PMC: 11288778. DOI: 10.1016/j.neuro.2024.06.016.


How Parkinson's Disease-Linked LRRK2 Mutations Affect Different CNS Cell Types.

Bailey H, Cookson M J Parkinsons Dis. 2024; 14(7):1331-1352.

PMID: 38905056 PMC: 11492021. DOI: 10.3233/JPD-230432.


LRRK2 mediates haloperidol-induced changes in indirect pathway striatal projection neurons.

Chen C, Masotti M, Shepard N, Promes V, Tombesi G, Arango D bioRxiv. 2024; .

PMID: 38895420 PMC: 11185612. DOI: 10.1101/2024.06.06.597594.


Cellular and subcellular localization of Rab10 and phospho-T73 Rab10 in the mouse and human brain.

Singh V, Menard M, Serrano G, Beach T, Zhao H, Riley-DiPaolo A Acta Neuropathol Commun. 2023; 11(1):201.

PMID: 38110990 PMC: 10726543. DOI: 10.1186/s40478-023-01704-9.


Modeling Parkinson's disease in LRRK2 rodents.

Domenicale C, Magnabosco S, Morari M Neuronal Signal. 2023; 7(3):NS20220040.

PMID: 37601008 PMC: 10432857. DOI: 10.1042/NS20220040.

References
1.
Alessi D, Sammler E . LRRK2 kinase in Parkinson's disease. Science. 2018; 360(6384):36-37. DOI: 10.1126/science.aar5683. View

2.
Cookson M . The role of leucine-rich repeat kinase 2 (LRRK2) in Parkinson's disease. Nat Rev Neurosci. 2010; 11(12):791-7. PMC: 4662256. DOI: 10.1038/nrn2935. View

3.
Satake W, Nakabayashi Y, Mizuta I, Hirota Y, Ito C, Kubo M . Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease. Nat Genet. 2009; 41(12):1303-7. DOI: 10.1038/ng.485. View

4.
Nalls M, Pankratz N, Lill C, Do C, Hernandez D, Saad M . Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease. Nat Genet. 2014; 46(9):989-93. PMC: 4146673. DOI: 10.1038/ng.3043. View

5.
Simon-Sanchez J, Schulte C, Bras J, Sharma M, Gibbs J, Berg D . Genome-wide association study reveals genetic risk underlying Parkinson's disease. Nat Genet. 2009; 41(12):1308-12. PMC: 2787725. DOI: 10.1038/ng.487. View